Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
48
NCT05487781
Phase 1 Clinical Study to Describe Biological Safety and Pharmacokinetics of Tyrphostin
Phase: Early Phase 1
Role: Lead Sponsor
Start: May 24, 2022
Completion: Jul 29, 2022